Anxiety disorders in people under the conditions of the coronavirus infection (COVID-19)
Автор: Saliev M. M., Agranovsky M. L., Azimova G. A., Muminov R. K.
Журнал: Экономика и социум @ekonomika-socium
Рубрика: Основной раздел
Статья в выпуске: 9 (88), 2021 года.
Бесплатный доступ
New research suggests that severe COVID-19 can cause delirium in the acute phase of the disease and then lead to depression, anxiety, chronic fatigue, insomnia and post-traumatic stress disorder. Currently, data on patients who have recovered from COVID-19 are very limited. However, one study reported that 33% of patients on discharge had a symptom complex characterized by inattention, disorientation, and poorly organized movements in response to a command.
Anxiety disorders, epidemic, coronavirus infection
Короткий адрес: https://sciup.org/140254912
IDR: 140254912
Список литературы Anxiety disorders in people under the conditions of the coronavirus infection (COVID-19)
- World Health Organization. Clinical guidelines for the management of patients with severe acute respiratory infection with suspected infection with a new coronavirus (2019-nCoV). Temporary recommendations. Publication data: January 25, 2020 [Electronic resource].
- Coronavirus (COVID-19). [electronic resource]. URL: https://coronavirus-monitor.ru . (data of the appeal 23.03.2020)
- Alserekhi H., Vali G., Alshukairi A., Alraddadi B. The effect of the Middle East respiratory syndrome coronavirus (MERS-COV) on pregnancy and perinatal outcomes. BMC Infects Dis. 2016; 16: 105-108.
- Bassetti M. New infections caused by the Chinese coronavirus (2019-nCoV): problems of storm control.
- Gu J., Han B., Jian Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020.
- Cao B., Wang Yu., Wen D. et al. Lopinavir-Ritonavir trial in adults hospitalized with severe Covid-19. New England Legal Medicine. 2020.
- Zhang L., Lin D., Sun H. et al. The crystal structure of the main protease of SARS-CoV-2 provides the basis for the development of improved α-ketoamide inhibitors. The science. 2020.
